Alexander KarpAlexander Karp earned $1B in 2024

In 2023, Geoffrey Parker earned $2.42M in total compensation at Allogene Therapeutics, including $724.00K salary, $270.60K bonus and $1.43M in stock. Most recently sold 4,361 shares in Feb 2025. Currently holds stock worth $2.45M. 2+ years at the helm of Allogene Therapeutics.

Compensation History

Annual executive compensation data for Geoffrey Parker, including salary, bonuses, and stock awards.

Year

2023

Total Compensation

$2.42M

Salary

$724.00K

Bonus

$270.60K

Other

$0.00

Salary

$724.00K

Board Justification

The compensation philosophy is designed to align executive compensation with performance and long-term shareholder value, with a significant portion of compensation tied to equity awards and performance metrics.

Bonus

$270.60K

Board Justification

Annual performance-based cash incentive earned for the year 2023, based on corporate goals achievement.

Other Compensation

$0.00

Board Justification

No additional compensation reported for 2023.

Restricted Stock

$1.43M444.11K RSU

Board Justification

Restricted Stock Units (RSUs) that vest 25% annually over four years, with 444,107 shares vested in 2023.

Performance Metrics

Performance metrics include achieving corporate goals related to clinical development and operational performance.

A

Geoffrey Parker

CEO of Allogene Therapeutics

Education

B.A. in Economics and Engineering Sciences from Dartmouth College; MBA from Stanford Graduate School of Business

Field of Expertise

Finance & Banking - Finance

Sector of Economy

Healthcare

Born

January 1, 1965 - 60 years ago

CEO of Allogene Therapeutics for

2 years 1 month (Oct 2023 - Present)

Previous Experience

Chief Operating Officer, Chief Financial Officer and Executive Vice President of Tricida, Inc.

Holdings

Track Geoffrey Parker's stock holdings and portfolio value over time.

Total Stock Sold

$7.28K

ALLO

$7.28K

4,361 ALLO shares

What if they kept their stock?

If Geoffrey Parker didn't sell their stock, today they would have:
Extra ALLO4,361 shares worth $6.24K.
This is -14.37% and $1.05K less than what they got when they sold the stock.

Insider Trading

Geoffrey Parker's recent stock transactions, purchases, and sales filed with the SEC.

ALLO

$7.54K

ALLO at $1.73/share

Feb 3, 2025

Sale

ALLO

173,913 shares

ALLO

Jan 24, 2025

Received

ALLO

$1.00M

ALLO at $2.90/share

May 16, 2024

Received

ALLO

$683.05

ALLO at $3.60/share

Jan 30, 2024

Purchase

ALLO

29,400 shares

ALLO

Jan 25, 2024

Received

ALLO

790,000 shares

ALLO

Oct 16, 2023

Received

PRGO

$330.64K

PRGO at $33.06/share

Jun 13, 2023

Purchase

PRGO

$190.27K

PRGO at $38.05/share

Mar 6, 2023

Purchase

PRGO

$184.27K

PRGO at $36.85/share

Dec 16, 2021

Purchase

PRGO

$103.22K

PRGO at $41.29/share

Mar 17, 2021

Purchase

Rivals

Compare Geoffrey Parker with competitor CEOs and industry peers.